Paragon 28 Remains Cautious Despite Hot Start to FY23

Paragon 28 reported 1Q23 orthopedic sales of $52 million, +25.8% compared to the first quarter of 2022.

The company's record-setting first quarter saw U.S. growth of 20% or better in all five subsegments within foot and ankle. Paragon 28 served more than 2,000 surgeons during the quarter, a 12% increase compared to the prior year, while...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us